ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,083.57
      0.36%
      US Tech 100
      21,188.40
      0.02%
      Dow Jones
      44,747.63
      0.00%
      Brent Oil
      74.675
      0.69%
      Bitcoin
      97,687.70
      1.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Xeris Biopharma Inc (0A8E) Quote

      Xeris Biopharma Inc

      Xeris Biopharma Inc (0A8E)

      LSE
      0.00
      0.00
      ( 0.00% )
      Updated: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      -
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      -
      Previous Close
      0.00
      Open
      -
      Last Trade
      2
      @
      292.673
      (O)
      Last Trade Time
      12:15:42
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      138,125,000
      Dividend Yield
      -
      PE Ratio
      -8.03
      Earnings Per Share (EPS)
      -0.45
      Revenue
      163.91M
      Net Profit
      -62.26M

      About Xeris Biopharma Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.xerispharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Xeris Biopharma Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0A8E. The last closing price for Xeris Biopharma was $0. Over the last year, Xeris Biopharma shares have traded in a share price range of $ 0.00 to $ 0.00.

      Xeris Biopharma currently has 138,125,000 shares outstanding. Xeris Biopharma has a price to earnings ratio (PE ratio) of -8.03.

      Ask ADVFN Intelligence (AI)

      0A8E Latest News

      More News

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 07 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 07 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 06 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 06 2021
      UK Regulatory

      Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc

      Lazard Asset Management 06 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS...

      October 06 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 Amend

      J.P. Morgan Securities LLC 05 October 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

      October 05 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 05 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 05 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 04 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 04 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 01 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 01 2021
      UK Regulatory

      Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC

      Morgan Stanley Smith Barney LLC 01 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      October 01 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 30 September 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

      September 30 2021
      UK Regulatory

      J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

      J.P. Morgan Securities LLC 30 September 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

      September 30 2021
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      0A8E - Frequently Asked Questions (FAQ)

      What is the current Xeris Biopharma share price?
      The current share price of Xeris Biopharma is $ 0.00
      How many Xeris Biopharma shares are in issue?
      Xeris Biopharma has 138,125,000 shares in issue
      What is the 1 year trading range for Xeris Biopharma share price?
      Xeris Biopharma has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Xeris Biopharma?
      The price to earnings ratio of Xeris Biopharma is -8.03
      What is the cash to sales ratio of Xeris Biopharma?
      The cash to sales ratio of Xeris Biopharma is 3.05
      What is the reporting currency for Xeris Biopharma?
      Xeris Biopharma reports financial results in USD
      What is the latest annual turnover for Xeris Biopharma?
      The latest annual turnover of Xeris Biopharma is USD 163.91M
      What is the latest annual profit for Xeris Biopharma?
      The latest annual profit of Xeris Biopharma is USD -62.26M
      What is the registered address of Xeris Biopharma?
      The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Xeris Biopharma website address?
      The website address for Xeris Biopharma is www.xerispharma.com
      Which industry sector does Xeris Biopharma operate in?
      Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ASTAscent Resources Plc
      1.90p
      (100.00%)
      		302.04k
      NTQEnteq Technologies Plc
      2.50p
      (38.89%)
      		14.47M
      GEXGeorgina Energy Plc
      7.00p
      (36.59%)
      		3.82M
      RAIRa International Group Plc
      0.95p
      (26.67%)
      		23.51M
      IMMImmupharma Plc
      4.80p
      (23.08%)
      		11.54M
      APQApq Global Limited
      2.00p
      (-69.23%)
      		54.36k
      BELLBelluscura Plc
      2.125p
      (-67.31%)
      		9.4M
      DEMGDeltex Medical Group Plc
      0.025p
      (-44.44%)
      		62.06M
      IOMIomart Group Plc
      47.00p
      (-20.88%)
      		1.54M
      SYMESupply@me Capital Plc
      0.002p
      (-20.00%)
      		527.26M
      SYMESupply@me Capital Plc
      0.002p
      (-20.00%)
      		527.26M
      ORCPOracle Power Plc
      0.016p
      (-19.19%)
      		383.69M
      NTVONativo Resources Plc
      0.0017p
      (0.00%)
      		279.02M
      CPAICapai Plc
      0.0485p
      (10.23%)
      		248.11M
      MSMNMosman Oil And Gas Limited
      0.0405p
      (3.85%)
      		136.24M

      Discussion

      View Full Feed
      ddls ddls 5 minutes ago
      Unfortunately being too kind to this junk company isn't helping it whatsoever...😎

      But, who knows, will see at the end of the day.
      BIEL
      TexasMarvL TexasMarvL 5 minutes ago
      I follow Tavi Costa posts on LinkedIn. 
      He has an interesting post and interesting chart almost every day.

      This link is to a chart of S&P500 YTD results.  The technology sector is down YTD.  All other sectors are up.  His post comments are that the market rotation has already s
      FFMGF
      Paulie Pennies Paulie Pennies 6 minutes ago
      TMI LOL I for one dont want to see what's behind a screen name 🤣
      ASII
      georgie18 georgie18 6 minutes ago
      Thanks...🥳
      M1Maggot M1Maggot 6 minutes ago
      Big Jump in the MTG NOTE ????? WTF was that for ??????
      CBRF
      Semper Fi 88 Semper Fi 88 6 minutes ago
      All the TS said was he would look at how release affects mortgage rates. Of course he would...it's the responsible thing to do now since rates are higher than normal. The Fed is already being pressured to lower rates and unemployment is bound to go up with all the Govt employees soon out of work as
      FNMA
      dennisdave dennisdave 6 minutes ago
      Are you basing your "no decision this month" simply on the average amount of time it takes to get to a decision once inspections are complete?
      yes purely my own estimate on the average amount t takes to get to a decision once inspections are complete (the median is 6 weeks if Im correct). Al
      NWBO
      BlazingStocks BlazingStocks 6 minutes ago
      $BURU News January 23, 2025

      Notice of Regaining Compliance with the NYSE
      https://finance.yahoo.com/news/notice-regaining-compliance-nyse-133000496.html
      BURU
      Screech691 Screech691 6 minutes ago
      Sustainable Green Team: Revolutionizing Gardening with Water-Less Garden! The Sustainable Green Team (SGTM) continues to innovate with their Water-Less Garden product. This sustainable gardening solution is designed to help conserve water while creating vibrant, thriving plants. It's perfect for hom
      SGTM
      sammdogg1 sammdogg1 6 minutes ago
      All these years, all those boards.
      IDCC
      kerrawill1122 kerrawill1122 7 minutes ago
      IBM has been a leader in technology and innovation for decades, consistently shaping the future of computing and AI. Its market position remains strong, reflecting investor confidence. For those exploring investment opportunities in various sectors, including real estate, estateagentsdagenham https:
      IBM
      harry crumb harry crumb 7 minutes ago
      No shares to short! This scam will be back at .20 quick
      MGOL
      Bionic Man Bionic Man 8 minutes ago
      Well, that's a given, but here, we don't get to look the cowards in the eyes hiding behind a screen name.
      ASII
      glenn1919 glenn1919 8 minutes ago
      UPC....FARM......LTRY........MGOL......TSLZ.......https://stockcharts.com/h-sc/ui?s=FARM&p=D&yr=0&mn=3&dy=0&id=p11960084343
      LTRY MGOL
      glenn1919 glenn1919 9 minutes ago
      PWM.......OCEA.....TSLZ......RZLV....MULN............................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      MULN OCEA PWM
      Konaploinks Konaploinks 9 minutes ago
      Comparing IonQ’s 1762-nm Optical Beam Approach to Other Quantum Computing Architectures

      IonQ’s approach using 1762-nm global optical beams in trapped-ion quantum computing stands out among competing quantum architectures. Let’s compare it to other leading approaches, including superco
      IONQ
      Natural Trader Natural Trader 10 minutes ago
      well said
      Invest-in-America Invest-in-America 10 minutes ago
      MGOL: Talk about VOLATILE price movement!!!
      MGOL
      jammy32 jammy32 10 minutes ago
      It’s amazing that the ceo placed a lid on the stock price by saying 50 cents seemed right. I searched and can’t see where other ceos have done this. I don’t get. We need some news.
      ELTP
      timberwolf7 timberwolf7 10 minutes ago
      One thing is for sure, a lot of people are dissapointed in this stock because of the high target of 583$

      Time to quit whining already. If you don't like whats going on, get out.

      Its that simple.

      Otherwise, re-visit WHY you got in in the first place
      TNXP
      dewophile dewophile 10 minutes ago
      Delaying earnings can be bad too but in this case there is far more potential for a positive catalyst even if there is no deal making. They already intimated they are looking to partner RSV so they can formalize that which means no further clinical development in antivirals after the adult HR study.
      ENTA
      Filterthenoise Filterthenoise 10 minutes ago
      FOXHO-HO-HO will filter out the snakes soon enough🎅
      RNVA
      beacham beacham 11 minutes ago
      Where do you go to challenge a deletion? I can't find it anywhere. I want to challenge the deletion of post # 337990 on the BIEL board. Why is there no link to 'post deletions' on the board itself?

      Your Recent History

      LSE
      0A8E
      Xeris Biopharma
      TG
      BY6
      BYD
      COIN
      ARIA20BTC
      ARIANEE
      BOV
      BPAN4M
      BANCO PAN PN
      DOWI
      DJBGIE
      DJ Brookfield Global Inf...
      USOTC
      RBXRF
      Rubix Resources (GM)
      BOV
      A9AB5L
      Agropast Asa Branca PNA
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads